June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Long Term Outcomes of Filtration Surgery for Normal-Tension Glaucoma with Visual Field Progression at Low Intraocular Pressure
Author Affiliations & Notes
  • Scott Schultz
    Ophthalmology, Bascom Palmer Eye Institute, Palm Beach Gardens, FL
  • Shawn Iverson
    Ophthalmology, Bascom Palmer Eye Institute, Palm Beach Gardens, FL
  • Wei Shi
    Ophthalmology, Bascom Palmer Eye Institute, Palm Beach Gardens, FL
  • Joyce Schiffman
    Ophthalmology, Bascom Palmer Eye Institute, Palm Beach Gardens, FL
  • David Greenfield
    Ophthalmology, Bascom Palmer Eye Institute, Palm Beach Gardens, FL
  • Footnotes
    Commercial Relationships Scott Schultz, None; Shawn Iverson, None; Wei Shi, None; Joyce Schiffman, None; David Greenfield, National Eye Institute (R), Carl Zeiss Meditec (R), Optovue (R), Heidelberg Engineering (R), Allergan (C), Alcon (C), Merz (C), Quark (C), SOLX (C), Biometric Imaging (C), Senju (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4762. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Scott Schultz, Shawn Iverson, Wei Shi, Joyce Schiffman, David Greenfield; Long Term Outcomes of Filtration Surgery for Normal-Tension Glaucoma with Visual Field Progression at Low Intraocular Pressure. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4762. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The purpose of this study was to examine the long-term outcome of glaucoma filtration surgery for progressive normal-tension glaucoma (NTG) at low intraocular pressure (IOP).

Methods: A retrospective chart review was conducted to identify NTG patients that underwent trabeculectomy with mitomycin C (MMC) between February 2006 and October 2010 for progressive visual field (VF) loss with preoperative intraocular pressure ≤ 15 mmHg during the 12-month period prior to surgery. All eyes had evidence of glaucomatous optic neuropathy and progressive VF loss, uncontrolled IOP on maximum medical therapy, and minimum postoperative follow-up of 12 months. Exclusion criteria consisted of age ≤ 18, recorded IOP > 22 mmHg, ocular disease other than glaucoma, or prior incisional surgery except uncomplicated cataract extraction. Failure was defined as IOP reduction < 20% below baseline (criteria 1), <30% (criteria 2), or <40% (criteria 3) on two consecutive follow-up visits after 3 months, reoperation for glaucoma, or loss of light perception, and was assessed using Kaplan-Meier survival analyses.

Results: Thirty eyes of 28 patients (mean age 73 ± 8.7 years) were enrolled with a mean follow-up period of 50 ± 31 mos. Mean postoperative IOP (8.3 ± 3.2 mmHg) and number of medications (0.6 ± 1.00) at final follow-up was significantly (p<0.001) reduced compared to prior to surgery (13.2 ± 1.4 mmHg and 2.5 ± 1.2, respectively). The cumulative probability of failure during 5 years of follow-up was 35% (criteria 1), 46%, (criteria 2), and 65% (criteria 3). Hypotony (IOP ≤ 5 mmHg on two consecutive follow-up visits after 3 months) was observed in 10 eyes. One eye developed clinical evidence of chorioretinal folds in the macula. Mean change in logMAR visual acuity in eyes (n=10) with hypotony (-0.14±0.18), was not significantly different (p=0.37) than eyes (n=20) without hypotony (-0.04±0.28). Other complications included CME (3), bleb leakage (2), endophthalmitis (1), blebitis (1), corneal edema (1), and choroidal effusion (1).

Conclusions: Trabeculectomy with MMC is an effective method for achieving long-term IOP reduction of 20-40% in NTG eyes with progression at low IOP. Hypotony is a common postoperative occurrence but did not result in a significantly greater degree of vision loss compared to the patients without hypotony in this series.

Keywords: 568 intraocular pressure  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×